NMNemaura Medical Inc. NMRD · OTC
$0.00 +0.00% (+$0.00)
- Market cap
- $4.04K
- Enterprise value
- $9.93M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 0.1x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -103.9%
- Gross margin
- -1,916.3%
- Net margin
- -18,358.0%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.92
- Free float
- 42.8%
About the company
Nemaura Medical Inc. (NMRD) is an American company specializing in innovative healthcare solutions and medical technologies. It is best known for its advanced device called SugarBEAT®, a painless and wireless monitoring device for tracking blood glucose levels in patients with diabetes mellitus. This innovative technology provides users with a convenient alternative to traditional methods of blood sugar monitoring. Nemaura Medical Inc. actively works on the development and improvement of its healthcare products. Shares of Nemaura Medical Inc. (NMRD) could be suitable for investors seeking investment opportunities in the field of medical technologies with an emphasis on innovation and improving the lives of patients with chronic conditions.
Sector
Healthcare
Industry
Medical - Devices
CEO
Dewan Fazlul Hoque Chowdhury
Employees
38
Headquarters
New York City
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number